// App-Quantinova.ai

SAT0218 (2017) : EFFECT OF TOCILIZUMAB IN DMARD-NAÏVE EARLY RHEUMATOID ARTHRITIS PATIENTS ON HEALTH-RELATED QUALITY OF LIFE: RESULTS OF THE U-ACT-EARLY TRIAL

Researchers

Presenter

  • X.M. Teitsma

Principal Investigators

  • J.W. Jacobs

  • P.M. Welsing

  • A. Peth-Schramm

  • M.E. Borm

  • J.M. van Laar

  • F.P. Lafeber

  • J.W. Bijlsma

Medical Centers

  • Rheumatology and Clinical Immunology,

  • UMC Utrecht, Utrecht, Netherlands

  • F. Hoffmann-La Roche Ltd., Basel, Switzerland

  • Roche Nederland BV, Woerden, Netherlands

Locations

  • Netherlands

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Tocilizumab

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Abbvie

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved